Dynamics of Organ Damage and Immune Exhaustion During Sepsis
NCT06817408 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-03-19
Summary
This is a prospective, non-randomized study investigating if organ damage and immune changes can be measured by liquid biopsy NGS through advanced analytical methods.
Conditions
Interventions
- OTHER
-
Observation
One additional blood draw in the Emergency Department as part of their standard of care visit.
Sponsors & Collaborators
-
National Institute of General Medical Sciences (NIGMS)
collaborator NIH - lead OTHER
Principal Investigators
-
Aadel A Chaudhuri, M.D., Ph.D. · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-25
- Primary Completion
- 2026-07-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
NCT01535534 ·Status: UNKNOWN
-
Mitochondrial DNA as a Biomarker of Sepsis Severity
NCT03077672 ·Status: COMPLETED
-
Identification Sepsis Related Single Nucleotide Polymorphism (SNP) by Whole Exome Sequencing
NCT01920217 ·Status: UNKNOWN
-
Validation of Molecular and Protein Biomarkers in Sepsis
NCT04289506 ·Status: UNKNOWN
-
Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe Sepsis
NCT02887274 ·Status: UNKNOWN
-
Novel Sepsis Sub-phenotypes Based on Trajectories of Vital Signs
NCT05826223 ·Status: COMPLETED
-
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
NCT05229328 ·Status: UNKNOWN
-
Function of Circulating Exosomes in Sepsis-induced Immunosuppression
NCT04979767 ·Status: UNKNOWN
-
Biomarkers in Exhaled Breath Condensates of Septic Patients to Predict Development of Multi-organ Dysfunction Syndrome
NCT01503684 ·Status: UNKNOWN
-
Mitochondrial Function of Immune Cells in Sepsis
NCT01600989 ·Status: COMPLETED
-
Defining Circulating Micro-RNA Biomarkers for the Early Diagnosis and Prognosis of Sepsis
NCT02544490 ·Status: COMPLETED
-
Molecular Diagnosis and Risk Stratification of Sepsis
NCT01905033 ·Status: UNKNOWN
-
Next-Generation Sequencing Diagnostics of Bacteremia in Sepsis
NCT03356249 ·Status: COMPLETED
-
A Prospective Observational Study of Sepsis
NCT05309889 ·Status: UNKNOWN
-
REAnimation Low Immune Status Markers
NCT02638779 ·Status: COMPLETED ·Phase: NA
-
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
NCT05052203 ·Status: UNKNOWN
-
Prognostic Interest of Leucocyte Immunophenotyping During the Acute Phase of Sepsis
NCT01995448 ·Status: COMPLETED
-
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
NCT06178822 ·Status: RECRUITING
-
Characterisation of Endothelial Cells in Different Inflammatory Pathologies
NCT06613256 ·Status: RECRUITING
-
Comparison of Sepsis Prediction Algorithms
NCT05943938 ·Status: NOT_YET_RECRUITING
-
Studies of Blood DNA in Patients With Severe Infection DYNAMICS
NCT01355042 ·Status: COMPLETED
-
Regulation of Endocrine, Metabolic, Immune and Bioenergetic Responses in Sepsis
NCT00187824 ·Status: UNKNOWN
-
Extracorporeal Membrane Oxygenation (ECMO): Blood Cells
NCT02748668 ·Status: TERMINATED
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN